Randomized controlled study of the T-type calcium channel antagonist MK-8998 for the treatment of acute psychosis in patients with schizophrenia

In Vitro Characterization of T-Type Calcium Channel Antagonist TTA-A2 and In Vivo Effects on Arousal in Mice

(2010) R. L. Kraus et al.   JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS

T-type calcium channel antagonism produces antipsychotic-like effects and reduces stimulant-induced glutamate release in the nucleus accumbens of rats

(2010) Jason M. Uslaner et al.   NEUROPHARMACOLOGY

Akathisia and second-generation antipsychotic drugs

(2009) Rajeev Kumar et al.   CURRENT OPINION IN PSYCHIATRY

Inhibition of recombinant Cav3.1 (α1G) T-type calcium channels by the antipsychotic drug clozapine

(2009) Kee-Hyun Choi et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

Antagonism of T-type calcium channels inhibits high-fat diet–induced weight gain in mice

(2009) Victor N. Uebele et al.   JOURNAL OF CLINICAL INVESTIGATION

Should baseline be a covariate or dependent variable in analyses of change from baseline in clinical trials?

(2009) Guanghan F. Liu et al.   STATISTICS IN MEDICINE

Regulation of T-type calcium channels: Signalling pathways and functional implications

(2008) Sylvaine Huc et al.   BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH

Discovery of 1,4-Substituted Piperidines as Potent and Selective Inhibitors of T-Type Calcium Channels

(2008) Zhi-Qiang Yang et al.   JOURNAL OF MEDICINAL CHEMISTRY

Second-generation versus first-generation antipsychotic drugs for schizophrenia: a meta-analysis

(2008) Stefan Leucht et al.   LANCET

What Is Causing the Reduced Drug-Placebo Difference in Recent Schizophrenia Clinical Trials and What Can be Done About It?

(2008) A. S. Kemp et al.   SCHIZOPHRENIA BULLETIN